Plasmapp Co

Plasmapp Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Plasmapp Co (405000.KQ) as of Oct 29, 2026 is -7.60 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -17.34 B KRW — a change of -56.15% (higher).

EBITDA

-7.60 BKRW

YoY

-56.15%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Plasmapp Co is 2025 -7.60 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Plasmapp Co was 2024 -17.34 B KRW. It decreases by -56.15% higher compared to the previous year.

The Plasmapp Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2021
-10.23 B KRW
Jan 1, 2022
-16.28 B KRW
Jan 1, 2023
-19.39 B KRW
Jan 1, 2024
-17.34 B KRW
Jan 1, 2025
-7.60 B KRW
The Plasmapp Co EBITDA history
YEAREBITDAYoY
-7.60 BKRW-56.15%
-17.34 BKRW-10.61%
-19.39 BKRW+19.10%
-16.28 BKRW+59.13%
-10.23 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Plasmapp Co Stock analysis

What does Plasmapp Co do? Plasmapp Co. Ltd. generates revenue through the provision of low temperature plasma sterilization solutions and implant regeneration and activation solutions. The company manufactures and sells medical devices including sterilizers, sterile consumables, regenerative activators, and related accessories. Its primary customers are healthcare providers and medical institutions requiring advanced sterilization and regenerative treatments. The firm targets the medical device segment with a focus on innovative plasma engineering applications for healthcare applications. The company's product portfolio consists of sterilizers, sterile consumables, regenerative activators, consumables, and accessories. These products are sold directly to healthcare facilities and medical institutions. The firm's technology enables low temperature plasma sterilization, which is critical for sensitive medical equipment and implant procedures. This specialization positions Plasmapp as a provider of niche medical solutions in the healthcare sector. Plasmapp Co. Ltd. focuses on the medical device market segment, particularly for sterilization and regenerative applications. The company's offerings include both hardware solutions like sterilizers and consumable products such as sterile consumables and regenerative activators. These products serve the needs of healthcare providers seeking efficient and advanced medical treatment solutions. Plasmapp Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Plasmapp Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Plasmapp Co is -7.60 B KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Plasmapp Co changed from -17.34 B KRW to -7.60 B KRW, representing a -56.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Plasmapp Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Plasmapp Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Plasmapp Co

All Key Metrics — Plasmapp Co